Shugan Jieyu capsules for depression relief
This study tests whether a traditional Chinese medicine called Shugan Jieyu capsules can safely and effectively reduce symptoms of depression. It's an observational, real-world trial, so it follows how the treatment works in everyday life rather than in a strictly controlled lab setting.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with depression by a doctor.
- You are between 13 and 65 years old.
- You haven't taken any antidepressants for at least 2 weeks (or 4 weeks if you took fluoxetine).
- You are willing to follow the study plan and attend all visits.
- Your depression is not considered treatment-resistant (meaning you haven't tried two or more different antidepressants without success).
- You do not have other serious mental health conditions like bipolar disorder.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 trial studies Shugan Jieyu Capsule to treat generalized anxiety disorder (GAD). It aims to see if it can reduce anxiety symptoms in people who fit specific anxiety severity and traditional diagnosis criteria.
This trial tests a new tablet, JS1-1-01, for people with moderate to severe depression. It aims to see if the tablet is effective and safe for treating depression symptoms.
This trial tests whether a traditional Chinese medicine capsule called Jieyu Chufan can safely and effectively reduce symptoms of depression. It may be a good option if you have moderate to severe depression and haven't taken antidepressants in the last 2 weeks.
This trial tests a combination of a traditional Chinese medicine formula (Zuojin Wan) with standard stomach-motility or acid-reducing drugs to see if it helps people who have both functional dyspepsia (upset stomach) and mild depression. It aims to improve both stomach symptoms and mood.
This study tests a gentle hands-on therapy based on Traditional Chinese Medicine, called Tui Jing, to see if it improves mood and brain function in people with depression. It lasts 12 weeks and compares the therapy with a placebo.
This trial tests a new medicine called LV232 for people with moderate to severe depression. Researchers want to find the best dose and check if it works safely.
Hear when a new Outpatients or Inpatients With Depression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.